Cannabis Psychedelics Eating Disorders: Research & Effects
Self-Medication with Drugs for Eating Disorder Symptoms: A Growing Trend
Table of Contents
Introduction
Eating disorders (EDs) – including anorexia nervosa, bulimia nervosa, binge-eating disorder (BED), and avoidant/restrictive food intake disorder (ARFID) – are serious mental illnesses with potentially life-threatening consequences. While customary treatments like psychotherapy and medication exist, many individuals find these insufficient to fully address their symptoms. A recent study published in JAMA Network Open reveals a significant trend of self-medication with a range of substances, both prescribed and illicit, among individuals with eating disorders. This article delves into the findings of this research, exploring which substances are being used, perceived benefits, reported side effects, and the implications for future research and clinical practice.
Key Findings of the Study
The study, conducted by researchers at the University of Sydney, surveyed a large cohort of individuals with self-reported eating disorders. participants detailed their use of various drugs - including prescription medications, cannabis, psychedelics, alcohol, and amphetamines – and rated their effects on three key areas using a 5-point Likert scale: eating disorder symptoms, overall mental health, and unpleasant side effects.
Here’s a breakdown of the moast significant findings:
Prevalence of Cannabis Use: cannabis was the most commonly reported substance used,with 56% of participants having tried it. Daily use was particularly prevalent among those with ARFID (odds ratio, 2.4; P < .001),suggesting a potential link between this specific eating disorder and cannabis self-medication.
Psychedelics and Cannabis for ED Symptoms: Both psilocybin and cannabis received the highest positive ratings for alleviating eating disorder symptoms (mean rating of 0.50 for both). lysergic acid diethylamide (LSD) also showed a positive, though lower, rating (mean rating of 0.3). This suggests a perceived benefit of these substances in managing core ED symptoms.
Antidepressants: Mixed Results: prescription antidepressants were generally rated as effective for improving overall mental health, but less so for directly addressing eating disorder symptoms. exceptions included lisdexamfetamine for BED (mean rating, 1.14) and fluoxetine for bulimia nervosa (mean rating, 0.50), indicating some efficacy for specific diagnoses.
Substances with Negative Ratings: Alcohol and amphetamines received the poorest ratings for symptom improvement (mean rating, -0.52 for both), highlighting their perceived ineffectiveness or even detrimental effects.
Side Effect Profiles: Lamotrigine (mean rating, -0.49), illicitly sourced diazepam (mean rating, -0.40),bupropion (mean rating,-0.29), and psilocybin (mean rating, -0.30) were associated with the fewest reported unpleasant adverse effects.
Implications for Clinical Practice
The study’s lead investigator, Sarah-Catherine Rodan, emphasized a crucial pattern: “These findings highlight an important pattern: with traditional medications often falling short in treating eating disorders directly, while many individuals are self-medicating with substances they perceive as helpful.” This observation underscores a significant gap in current treatment approaches and the need for clinicians to be aware of the prevalence of self-medication among their patients.
Understanding why individuals are turning to these substances is critical. Possible motivations include:
Appetite Suppression: Some substances, like cannabis and amphetamines, might potentially be used to suppress appetite, particularly in anorexia nervosa or restrictive subtypes of other EDs.
mood Regulation: Eating disorders are often comorbid with anxiety,depression,and other mood disorders. Individuals may self-medicate with substances perceived to alleviate these symptoms.
Emotional Numbing: Substances can provide temporary relief from the intense emotional distress frequently enough associated with eating disorders.
* Altered Perception: Psychedelics may offer altered states of consciousness that some individuals find helpful in processing trauma or challenging distorted body image.
clinicians shoudl approach conversations about substance use with empathy and non-judgment, recognizing that self-medication frequently enough stems from a desire to cope with overwhelming symptoms. Openly discussing these behaviors can create a safe space for patients to disclose their experiences and explore alternative, evidence-based treatment options.
The Potential of Cannabis and Psychedelics: A Call for Research
The positive ratings for cannabis and psychedelics in alleviating ED symptoms warrant further inquiry. Rodan advocates for “more research, including large clinical trials, should be undertaken around the beneficial effects of cannabis and psychedelics for people with eating disorders.”